GenMark Diagnostics, Inc. - FORM 10-K - EX-32.1 - CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER - March 11, 2011

Attached files

file filename
10-K - FORM 10-K - GenMark Diagnostics, Inc.d10k.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - GenMark Diagnostics, Inc.dex311.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - GenMark Diagnostics, Inc.dex312.htm
EX-23.2 - CONSENT OF DELOITTE TOUCHE LLP (UK) - GenMark Diagnostics, Inc.dex232.htm
EX-23.1 - CONSENT OF DELOITTE TOUCHE LLP (US) - GenMark Diagnostics, Inc.dex231.htm
EX-10.27 - THIRD AMENDMENT TO LOAN SECURITY AGREEMENT - GenMark Diagnostics, Inc.dex1027.htm
EX-10.25 - FIRST AMENDMENT TO LOAN SECURITY AGREEMENT - GenMark Diagnostics, Inc.dex1025.htm
EX-10.26 - SECOND AMENDMENT TO LOAN SECURITY AGREEMENT - GenMark Diagnostics, Inc.dex1026.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of GenMark Diagnostics, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2010, as filed with the Securities and Exchange Commission (the “Report”), Christopher Gleeson, Interim Chief Executive Officer of the Company, does hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  •  

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  •  

The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 11, 2011

 

/s/ Christopher Gleeson

Christopher Gleeson

Interim Chief Executive Officer (principal executive officer and principal financial officer)

GenMark Diagnostics, Inc. Reports